tiprankstipranks
Summit Therapeutics PLC (SMMT)
NASDAQ:SMMT
US Market
Want to see SMMT full AI Analyst Report?

Compare Summit Therapeutics (SMMT) vs. Competitors

1,903 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Summit Therapeutics
$25.15
$12.90B
-19.40
-35.51%
9 Buy
4 Hold
1 Sell
Moderate Buy
Incyte
$97.82
$19.41B
15.46
50.61%
8 Buy
9 Hold
1 Sell
Moderate Buy
United Therapeutics
$588.38
$24.13B
23.46
84.12%
11 Buy
3 Hold
0 Sell
Strong Buy
Ascendis Pharma
$244.48
$15.41B
4.77
54.36%
14 Buy
0 Hold
0 Sell
Strong Buy
Genmab
$28.55
$15.98B
77.40
27.77%
7 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$102.92
$23.30B
-8.99
-7.00%
14 Buy
3 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SMMT
Summit Therapeutics
16.62
-9.02
-35.18%
INCY
Incyte
97.16
32.91
51.23%
UTHR
United Therapeutics
568.43
260.78
84.77%
ASND
Ascendis Pharma
247.05
89.78
57.09%
GMAB
Genmab
26.87
6.06
29.12%
BNTX
BioNTech SE
92.14
-6.41
-6.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts